West Virginia Telehealth: Establishing a Valid Provider-Patient Relationship and Prescribing Requirements

West Virginia has proactively developed a regulatory framework to facilitate the delivery of healthcare services via telehealth, including provisions for establishing a valid provider-patient relationship and prescribing medications. These regulations are critical for healthcare providers seeking to leverage telehealth technologies to serve patients within the state.

Defining Telehealth in West Virginia

West Virginia Code §16-29I-2 defines "telehealth" as the use of synchronous or asynchronous telecommunications technology by a health care provider to provide health care services, including, but not limited to, assessment, diagnosis, consultation, treatment, and monitoring, to a patient at a different physical location than the health care provider. This broad definition allows for various modalities, though specific requirements often apply based on the service rendered.

Establishing a Valid Provider-Patient Relationship via Telehealth

One of the most crucial aspects of telehealth regulation is the establishment of a legitimate provider-patient relationship. West Virginia law generally permits this relationship to be established through a telehealth encounter, provided certain conditions are met. Unlike some states that require an initial in-person visit, West Virginia allows for the initial encounter to occur via synchronous audio-visual technology.

The West Virginia Board of Medicine, which regulates physicians and physician assistants, outlines these requirements in its legislative rules. Specifically, 11 CSR 1A §13.4.a states that a physician may establish a physician-patient relationship via telehealth if the physician:

• Obtains a medical history and performs an appropriate physical examination, either in-person or through real-time interactive audio-visual technology.
• Discusses the diagnosis and treatment plan with the patient.
• Ensures the patient's informed consent for treatment, including the limitations of telehealth.
• Maintains appropriate medical records of the encounter.

This means that a comprehensive evaluation, equivalent to an in-person visit, must be conducted remotely. The use of real-time interactive audio-visual technology is generally preferred for establishing this initial relationship, as it allows for a more thorough assessment than audio-only or asynchronous methods for many types of care. (Source: West Virginia Board of Medicine, Legislative Rule 11 CSR 1A, §13.4.a, https://www.wvbom.wv.gov/)

Prescribing Medications via Telehealth

West Virginia law differentiates between prescribing non-controlled substances and controlled substances via telehealth.

Non-Controlled Substances

For non-controlled substances, West Virginia permits prescribing after a valid provider-patient relationship has been established through a telehealth encounter, provided the prescribing practitioner adheres to the same standard of care as if the encounter were in-person. This includes:

• Performing an appropriate evaluation of the patient.
• Establishing a diagnosis based on the evaluation.
• Developing a treatment plan that is medically necessary and appropriate.
• Maintaining proper medical records of the encounter and prescription.

The West Virginia Board of Pharmacy also emphasizes that all prescriptions, whether issued in-person or via telehealth, must comply with all applicable state and federal laws and regulations governing prescription orders. (Source: West Virginia Board of Pharmacy, Legislative Rule 15 CSR 1, §12.3, https://www.wvbop.com/)

Controlled Substances

Prescribing controlled substances via telehealth is subject to stricter regulations, largely aligning with federal requirements under the Ryan Haight Online Pharmacy Consumer Protection Act of 2008. Generally, a prescription for a controlled substance is not valid unless the prescribing practitioner has conducted an in-person medical evaluation of the patient. However, there are exceptions, particularly in the context of the federal Public Health Emergency (PHE) waivers and specific state allowances.

During the federal COVID-19 PHE, the DEA waived the in-person examination requirement for controlled substance prescriptions via telehealth. As of the time of this article, the DEA has extended certain flexibilities, but the long-term rules are still being finalized. West Virginia law generally defers to federal law regarding controlled substances. Therefore, unless a federal waiver is in effect or a specific exception applies (e.g., for patients in hospitals or certain long-term care facilities), an initial in-person examination is typically required before a controlled substance can be prescribed via telehealth. (Source: DEA Diversion Control Division, Telemedicine, https://www.dea.gov/)

West Virginia Code §16-51-1 et seq., the "West Virginia Controlled Substances Act," also governs the prescribing, dispensing, and administering of controlled substances and requires practitioners to act within the usual course of professional practice. This implicitly requires a legitimate medical purpose and a proper provider-patient relationship.

Standard of Care and Documentation

Regardless of the type of substance prescribed or the nature of the telehealth service, West Virginia law mandates that the standard of care provided via telehealth must be the same as the standard of care for in-person services. This means that providers are expected to exercise the same level of diagnostic and therapeutic skill and care as they would in a traditional setting.

Comprehensive documentation is crucial. Medical records for telehealth encounters must be maintained in the same manner as for in-person encounters, including:

• Patient identification and demographics.
• Relevant medical history.
• Findings from the telehealth evaluation.
• Diagnosis.
• Treatment plan, including any prescriptions issued.
• Informed consent for telehealth services.
• Identity of the licensed healthcare professional providing the service.
• Date and type of telehealth service provided.

Failure to meet the standard of care or maintain adequate documentation can lead to professional disciplinary action by the respective licensing boards.

Implications for Specific Specialties

• Telehealth Brands & Primary Care: Can establish relationships and prescribe non-controlled substances after a synchronous audio-visual evaluation. Controlled substance prescribing generally requires an in-person visit or a federal waiver.
• Medspas & Dermatology: For aesthetic treatments involving prescription products (e.g., certain injectables, compounded topicals), a valid provider-patient relationship must be established via telehealth, adhering to the same standard of care. Prescribing controlled substances like sedatives would require an in-person visit.
• Mental Health: Can utilize telehealth extensively for therapy and medication management of non-controlled substances. Prescribing controlled substances for conditions like anxiety or ADHD will generally require an initial in-person visit or adherence to federal waivers.
• Dental Practices: Can use telehealth for consultations, follow-ups, and potentially prescribing non-controlled antibiotics or pain medications after a proper telehealth evaluation. Prescribing controlled substances for acute pain would typically require an in-person visit.
• Chiropractic Offices: While chiropractors do not prescribe medication, their telehealth consultations must still establish a legitimate provider-patient relationship and adhere to the standard of care for their scope of practice.

Conclusion

West Virginia has embraced telehealth as a legitimate mode of healthcare delivery, offering a relatively flexible framework for establishing provider-patient relationships through synchronous audio-visual technology. However, this flexibility is coupled with stringent requirements for maintaining the standard of care, obtaining informed consent, and meticulous documentation. Practitioners and healthcare businesses operating in West Virginia must thoroughly understand and comply with these state-specific rules, particularly regarding the differentiation between controlled and non-controlled substance prescribing, to ensure legal and ethical practice. Ongoing monitoring of federal DEA guidance for controlled substance prescribing via telehealth is also essential.